Canakinumab for the Treatment of Postprandial Hypoglycemia

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Canakinumab for the Treatment of Postprandial Hypoglycemia	Nutritional and Metabolic Diseases, Postprandial Hypoglycemia, glucose metabolism disease, hypoglycemia, metabolic disease	Recruiting	Phase 3	2025-01-29		NCT05401578

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
University Hospital, Basel, Switzerland	243

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Cantonal Hospital Olten, Division of Endocrinology	Olten	Switzerland	1
University Hospital Basel, Division of Endocrinology, Diabetes and Metabolism	Basel	Switzerland	1

Clinical trials